|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.51 USD | +6.81% |
|
+14.09% | +9.61% |
| 15/07 | Checkpoint Therapeutics, GC Cell Collaborate on Cancer Research; Shares Rise | MT |
| 15/07 | GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research | CI |
Checkpoint Therapeutics, Inc. announced that it has entered into a securities purchase agreement to issue pre funded common warrants at a price of $2.0499 on July 2, 2024. The warrants will be exercisable into 5,853,659 shares at an exercise price of $0.0001.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.61% | 9.56Cr | |
| +22.15% | 4.66TCr | |
| +45.32% | 4.17TCr | |
| -2.37% | 4.12TCr | |
| +33.84% | 3.24TCr | |
| -6.35% | 2.81TCr | |
| +20.42% | 2.82TCr | |
| +48.83% | 1.45TCr | |
| +45.00% | 1.37TCr | |
| +0.06% | 1.22TCr |
CHECKPOINT THERAPEUTICS, INC. 
